Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
Experimental Hematology & Oncology
|
August 23, 2025
The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation
Bianca Stiller, Alessia Stefanelli, Hemma Schueffl, et al.
Oncoimmunology
|
October 3, 2022
Tyk2 is a tumor suppressor in colorectal cancer
Stefan Moritsch, Bernadette Mödl, Irene Scharf, et al.
EMBO Molecular Medicine
|
May 25, 2023
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
Barizah Malik, Iva Vokic, Thomas Mohr, et al.
Science Translational Medicine
|
December 13, 2019
Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
Jörg Klufa, Thomas Bauer, Buck Hanson, et al.
Cell Death and Differentiation
|
June 2, 2026
EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer
Ourania Fari, Angelika Neuhofer, Martin Holcmann, et al.
Molecular Oncology
|
July 3, 2020
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity
Sandra Grund-Gröschke, Daniela Ortner, Antal B Szenes-Nagy, et al.
Nature Cancer
|
January 23, 2025
Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells
Martina Sanlorenzo, Philipp Novoszel, Igor Vujic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 31, 2011
High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation
Eva Sallmann, Bärbel Reininger, Sabine Brandt, et al.
The EMBO Journal
|
November 19, 2013
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Mircea Winter, Mirjam A Moser, Dominique Meunier, et al.
Cancer Cell
|
June 13, 2018
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
Debanjan Dhar, Laura Antonucci, Hayato Nakagawa, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
Experimental Hematology & Oncology
|
August 23, 2025
The anticancer thiosemicarbazone triapine exerts immune-enhancing activities via immunogenic cell death induction and FAS upregulation
Bianca Stiller, Alessia Stefanelli, Hemma Schueffl, et al.
Oncoimmunology
|
October 3, 2022
Tyk2 is a tumor suppressor in colorectal cancer
Stefan Moritsch, Bernadette Mödl, Irene Scharf, et al.
EMBO Molecular Medicine
|
May 25, 2023
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
Barizah Malik, Iva Vokic, Thomas Mohr, et al.
Science Translational Medicine
|
December 13, 2019
Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
Jörg Klufa, Thomas Bauer, Buck Hanson, et al.
Cell Death and Differentiation
|
June 2, 2026
EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer
Ourania Fari, Angelika Neuhofer, Martin Holcmann, et al.
Molecular Oncology
|
July 3, 2020
Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity
Sandra Grund-Gröschke, Daniela Ortner, Antal B Szenes-Nagy, et al.
Nature Cancer
|
January 23, 2025
Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells
Martina Sanlorenzo, Philipp Novoszel, Igor Vujic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 31, 2011
High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation
Eva Sallmann, Bärbel Reininger, Sabine Brandt, et al.
The EMBO Journal
|
November 19, 2013
Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
Mircea Winter, Mirjam A Moser, Dominique Meunier, et al.
Cancer Cell
|
June 13, 2018
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
Debanjan Dhar, Laura Antonucci, Hayato Nakagawa, et al.
Page
of 12